Novo Nordisk A/S
看多

Correction Over?

411
Head and Shoulders pattern complete, we are 32% down from all time high.
We have retraced to the 0.5 Fib level and bounced at the key $100 level.
Trade entered with a tight stop loss, in case we lose that key $100 level.

The correction may be over in this top Pharma stock. Eli had terrible earnings but Novo looks more promising at this stage. Cagrisema phase 3 results due in the next 4 weeks.

Not financial advise, do what's best for you.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。